**Core Concept**
HMB 45 is a monoclonal antibody that reacts with an antigen present in melanocytic tumors, making it a specific marker for identifying cells of melanocytic lineage. This antibody is primarily used in immunohistochemistry to detect melanomas and other melanocytic lesions.

**Why the Correct Answer is Right**
HMB 45 specifically targets the melanoma-associated antigen p97, a protein expressed in melanocytic tumors. This antigen is present in a significant proportion of melanomas, particularly those of epithelioid and spindle cell types. The use of HMB 45 in combination with other markers like S-100 and melan-A helps in the accurate diagnosis of melanoma, especially in cases where the diagnosis is challenging.

**Why Each Wrong Option is Incorrect**
**Option B:** Mesothelioma is typically associated with markers like calretinin, WT1, and cytokeratin 5/6, but not HMB 45.
**Option C:** Bronchogenic carcinoma often expresses markers like TTF-1, Napsin A, and p63, which are not related to HMB 45.
**Option D:** Pancreatic carcinoma may express markers like CA 19-9, CEA, and pancreatic-specific antigen, but HMB 45 is not a relevant marker for this condition.

**Clinical Pearl / High-Yield Fact**
It's essential to remember that HMB 45 is not specific for melanoma and can also be positive in other melanocytic lesions like blue nevi and neurofibromas. Therefore, a positive result should be interpreted in conjunction with other histological and immunohistochemical features.

**✓ Correct Answer: A. Malignant melanoma**